Extracellular matrix and tenascin-C in pathogenesis of breast cancer
- 1 June 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 357 (9273) , 1992-1994
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tenascin—A Marker for the Malignant Potential of Preinvasive Breast CancersGynecologic Oncology, 2000
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesisNature Cell Biology, 2000
- Laminin Inhibits Estrogen Action in Human Breast Cancer Cells1Endocrinology, 2000
- Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.Endocrine-Related Cancer, 2000
- The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary CarcinogenesisCell, 1999
- Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biologyProceedings of the National Academy of Sciences, 1998
- Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrenceBritish Journal of Cancer, 1998
- Expression of Tenascin-C in intraductal carcinoma of human breast: relationship to invasionEuropean Journal of Cancer, 1998
- Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.Journal of Clinical Oncology, 1996
- Targeting the EGF receptor in breast cancer treatmentBreast Cancer Research and Treatment, 1994